M. Muñoz

Simplification to dual therapy (atazanavir/ritonavir + lamivudine) versus standard triple therapy [atazanavir/ritonavir + two nucleos(t)ides] in virologically stable patients on antiretroviral therapy: 96 week results from an open-label, non-inferiority, randomized clinical trial (SALT study)

B. Clotet, M. Odriozola, J. Olalla, 2017, The Journal of antimicrobial chemotherapy.

Middle term intestinal adaptation after massive distal small bowel resection in oral feeding dogs.

I. Núñez de Castro, M. García-Caballero, J. Ruiz, 1996, Nutricion hospitalaria.